%0 Journal Article
%T Preimplantation genetic testing in the current era, a review.
%A Tian Y
%A Li M
%A Yang J
%A Chen H
%A Lu D
%J Arch Gynecol Obstet
%V 309
%N 5
%D 2024 May 20
%M 38376520
%F 2.493
%R 10.1007/s00404-024-07370-z
%X <B>BACKGROUND: </B>Preimplantation genetic testing (PGT), also referred to as preimplantation genetic diagnosis (PGD), is an advanced reproductive technology used during in vitro fertilization (IVF) cycles to identify genetic abnormalities in embryos prior to their implantation. PGT is used to screen embryos for chromosomal abnormalities, monogenic disorders, and structural rearrangements.<BR><B>UNASSIGNED: </B>Over the past few decades, PGT has undergone tremendous development, resulting in three primary forms: PGT-A, PGT-M, and PGT-SR. PGT-A is utilized for screening embryos for aneuploidies, PGT-M is used to detect disorders caused by a single gene, and PGT-SR is used to detect chromosomal abnormalities caused by structural rearrangements in the genome.<BR><B>OBJECTIVE: </B>In this review, we thoroughly summarized and reviewed PGT and discussed its pros and cons down to the minutest aspects. Additionally, recent studies that highlight the advancements of PGT in the current era, including their future perspectives, were reviewed.<BR><B>CONCLUSIONS: </B>This comprehensive review aims to provide new insights into the understanding of techniques used in PGT, thereby contributing to the field of reproductive genetics.